Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02157610 · ClinicalTrials.gov registry record · NA
Smoking Cessation for Cervical Cancer Survivors
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT02157610: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT02157610 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 202 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02157610, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
The goal of this research study is to compare a program called Motivation And Problem-Solving (MAPS) to the standard treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.
Primary Outcome
To test treatment effect at 18 months, logistic regression analysis conducted with abstinence as outcome variable, and treatment (a two-level categorical variable) as predictor, adjusting for covariates, specifically, factors used in the minimization procedures (race/ethnicity, language, age, education, income, cigarettes/day, cervical cancer stage, and time since diagnosis). A logit link and binomial variance function assumed for generalized linear mixed model (GLMM), regression and parameteriz
Interventions
- DRUG Nicotine Patch
- BEHAVIORAL Telephone Counseling Sessions
- BEHAVIORAL Self-Help Materials
- BEHAVIORAL REDCap
- PROCEDURE Saliva Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2015-01 |
| Est. Completion | 2021-08 |
| Phase | NA |
What the finished NCT02157610 record still lists
NCT02157610 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 5 interventions - of which Nicotine Patch is the first listed.
NCT02157610 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02157610 about?
NCT02157610 is a clinical study titled "Smoking Cessation for Cervical Cancer Survivors". The goal of this research study is to compare a program called Motivation And Problem-Solving (MAPS) to the standard treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.
What is the current status of trial NCT02157610?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2015-01. Estimated completion is 2021-08.
What interventions are being tested in trial NCT02157610?
The interventions under investigation include: Nicotine Patch (DRUG), Telephone Counseling Sessions (BEHAVIORAL), Self-Help Materials (BEHAVIORAL), REDCap (BEHAVIORAL), Saliva Test (PROCEDURE).
Who is sponsoring clinical trial NCT02157610?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02157610's enrollment target sits among peer trials
202 505th of 2000 higher than 1,495 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05272254 · 202 participants · Phase 2
Povidone Iodine Efficacy Study
- NCT05701280 · 202 participants · NA
Pilot/Pivotal Study of DBS+Rehab After Stroke
- NCT05932589 · 202 participants
Neurophysiologic Biomarkers in Rett Syndrome
- NCT06014931 · 202 participants · NA
Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia